For instance, MUC1 has been reported to be expressed during liver cancer progression, and the genetic knockdown or antibody-mediated targeting of MUC1 has been shown to inhibit its tumor-promoting functions in HCC [264,265,268,269,270]. This evidence concerns the gene MUC1 and hepatocellular carcinoma.